Interrupted Aortic Arch — #4 Staged (Two-Stage) Repair

Date
November 10, 2025
URL
https://x.com/WithAScalpel/status/1987867205564813361?s=20
Categories
Interrupted Aortic ArchCardiac Surgery

Interrupted Aortic Arch — #4 Staged (Two-Stage) Repair

image

Rationale and clinical context

A staged pathway is appropriate when the neonate is physiologically fragile (low output, acidosis, end-organ injury, severe overcirculation) or when immediate two-ventricle repair is unsafe because of anatomy (remote/malaligned VSD, borderline/subaortic LVOT) or size. Three goals guide the strategy: (1) secure systemic perfusion, (2) titrate pulmonary blood flow (PBF) to avoid lung injury and heart failure, and (3) permit organ recovery and somatic/PA growth before definitive repair. Decision-making should explicitly account for LVOT size; a practical heuristic supports standard repair if LVOT (mm) ≥ weight (kg) + 2, and LVOT bypass (e.g., Yasui/Norwood) if LVOT (mm) ≤ weight (kg) [1]. Contemporary registry data indicate that, in IAA/VSD with severe LVOTO, staging reduces major complications compared with primary complex biventricular repair, with similar mortality [2].

Stage 1 options

A) Bilateral PAB + PDA stent (catheter-based or hybrid)

Purpose. Deliver controlled PBF while preserving descending aortic/systemic perfusion via a stented ductus.

Evidence. In high-risk neonates/early infants (including IAA+VSD±LVOTO), an initial hybrid (bilateral PAB + ductal stent) enabled later biventricular repair in most survivors (conversion at 8–13 months in a seminal series) and provided a bridge to Yasui when LVOT remained nonresectable [3]. Multicenter and institutional experiences show that hybrid palliation can promote left-heart/LVOT growth and increase the proportion ultimately eligible for biventricular repair, albeit with frequent interstage/reintervention needs typical of this pathway [4].

Why it helps. It avoids CPB during maximal vulnerability; PABs cap Qp to mitigate edema, and ductal stenting safeguards lower-body perfusion and diastolic pressure.

Technical pearls.

  • Place bands ~2–3 mm proximal to lobar take-offs; target Qp:Qs ≈ 0.7–1.0 (systemic sats mid-70s–low-80s with acceptable lactate).
  • Select a PDA stent spanning the entire duct without jailing LPA/DAo; institute antiplatelet therapy and close imaging follow-up.
  • Maintain a generous ASD for atrial mixing.

    • Pitfalls. Band malposition/branch PA distortion and stent migration/thrombosis; after debanding, expect higher rates of PA interventions and increased RV pressure load if local stenosis persists—warranting systematic surveillance and a low threshold for catheter dilation or PA plasty [5]. Case-level evidence in IAA shows feasibility of hybrid → Yasui when LVOT remains restrictive [6].

B) Early arch repair + main PAB

When to choose. When arch reconstruction is feasible now but immediate intracardiac completion is hazardous (e.g., unfavorable VSD tunneling route, marginal LVOT, or physiologic frailty).

Concept. Perform arch repair with ACP to normalize systemic outflow, then place a main PAB to restrain PBF until the patient grows and recovers, deferring complex VSD/LVOT work.

Benefits & cautions. This approach restores native systemic perfusion early and avoids prolonged neonatal cross-clamp for complex rerouting. Monitor for PA hypertension or inadequate restriction; plan for band takedown and branch PA reconstruction at Stage 2.

Stage 2 (definitive repair)

Timing. After weeks–months of stabilization and growth, with recovered end-organ function and favorable imaging.

Operation.

  • Complete arch repair if not yet done.
  • VSD closure/rerouting to establish true biventricular circulation.
  • PAB takedown with branch PA plasty as needed.
  • Yasui (Norwood–Rastelli) if the LVOT remains restrictive (small annulus or unamenable tunnel): create a DKS for systemic outflow and route LV blood across the VSD to the neo-aorta. Contemporary series show excellent early survival and sustained ventricular function, with low mid-term LVOTO reoperation but an expected burden of RV-PA conduit reinterventions [7, 8].

Patient selection and pre-stage considerations

  • Arch & LVOT anatomy. Aortic valve/LVOT/ascending aorta size and geometry drive risk of residual LVOTO; apply weight-based LVOT thresholds when planning standard vs LVOT-bypass strategies [1].
  • VSD morphology. Size, location, and alignment determine feasibility of conal resection vs tunnel and inform conduction-risk counseling.
  • Hemodynamics/organ status. Lactate, renal/hepatic indices, NIRS, ventilatory/oxygen needs; staging favored when these are suboptimal or when sepsis/NEC is present [3, 5].
  • Ventricular/coronary function. Depressed LV function or significant TR/RV dysfunction favors initial physiologic decompression with tight PBF control.

Postoperative management targets

  • Maintain balanced Qp:Qs (systemic sats ~75–85% with acceptable lactate and stable cerebral/somatic NIRS).
  • Antiplatelet therapy for PDA stents; anticoagulation per protocol.
  • Serial echocardiography/cross-sectional imaging for band tightness, branch PA growth, arch gradient, ventricular function, and LVOT evolution.
  • Nutrition and interstage monitoring to optimize somatic and PA growth before completion; anticipate and schedule catheter-based PA/arch touch-ups as needed [5].

Common failure modes and how to avoid them

  • Bands too tight/loose. Titrate to physiology; revise early if sats/CO₂/lactate drift.
  • Branch PA distortion. Precise band placement; be liberal with PA plasty at takedown and plan catheter angioplasty per surveillance findings [5].
  • Recurrent arch obstruction. Aim for robust initial relief; maintain a low threshold for arch ballooning/stenting in the interstage.
  • Stent issues (thrombosis, migration, LPA jailing). Size carefully; ensure full-length ductal coverage and close imaging follow-up with early antiplatelet therapy [3, 6].
  • Persistent LVOTO risk. Use weight-based LVOT criteria and selective LVOT-bypass (Yasui) in neonates with inadequate LVOT dimensions; outcomes are favorable with conscientious conduit surveillance [1, 7, 8].

Why staged repair now? (Evidence snapshot)

  • Risk-matched advantage: In IAA/VSD with severe LVOTO, staged pathways were linked to fewer major complications than primary neonatal Yasui/Ross, without a mortality penalty [2].
  • Bridge to growth/clarity: Hybrid bilateral PAB + PDA stent can stabilize physiology and promote left-heart/LVOT growth, enabling later biventricular conversion or clarifying the need for Yasui [3, 4, 6].
  • Known trade-offs: Expect higher PA reintervention burden after banding/debanding; build this into surveillance and consent [5].
  • Definitive option: When LVOT remains restrictive, Yasui offers durable systemic outflow with low early mortality and preserved ventricular function; mid-term LVOTO reoperation is uncommon, but RV-PA conduit reinterventions are frequent and anticipated [7, 8].

References

[1] Tchervenkov CI, Jacobs JP, Sharma K, Ungerleider RM. Interrupted aortic arch: surgical decision making. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2005;8:92-102. PubMed

[2] Nellis JR, Scherba JC, Meza JM, Turek JW, Andersen ND. Primary vs Staged Biventricular Repair for Neonatal IAA with VSD and LVOTO. Ann Thorac Surg Short Rep. 2024;2(4):815-819. PubMed

[3] Erek E, Suzan D, Aydin S, Temur B, Demir IH, Odemis E. Staged biventricular repair after hybrid procedure in high-risk neonates and infants. World J Pediatr Congenit Heart Surg. 2019;10(4):426-432. PubMed

[4] Sojak V, Bokenkamp R, Kuipers IM, Schneider A, Hazekamp MG. Left heart growth and biventricular repair after hybrid palliation. Interact Cardiovasc Thorac Surg. 2021;32(5):792-799. PubMed

[5] Uhl S, Grieshaber P, Arnold R, Loukanov T, Gorenflo M, et al. Impact of hybrid procedure on pulmonary arterial dimensions and right ventricular load after biventricular repair. J Cardiothorac Surg. 2023;18:65. BioMed Central

[6] Lee J, Ko SM, Ku M, et al. Staged repair after hybrid palliation for interrupted aortic arch and severe LVOT obstruction. Korean J Thorac Cardiovasc Surg. 2019;52(1):45-49. PMC

[7] Kanter KR, Kirshbom PM, Kogon BE. Biventricular repair with the Yasui operation (Norwood/Rastelli) for systemic outflow tract obstruction with two adequate ventricles. Ann Thorac Surg. 2012;93(6):1999-2005. PubMed

[8] Greene CL, Scully B, Staffa SJ, et al. The Yasui operation: A single institutional experience over 30 years. JTCVS Open. 2023;15:361-367. PubMed+1